523 (Cefpodoxime 200 mg)
Pill imprint 523 has been identified as Cefpodoxime proxetil 200 mg.
Cefpodoxime is used in the treatment of skin infection; upper respiratory tract infection; bladder infection; sinusitis; pneumonia (and more), and belongs to the drug class third generation cephalosporins. There is no proven risk in humans during pregnancy. Cefpodoxime 200 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for 523 (Cefpodoxime 200 mg)
Cefpodoxime proxetil is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...